Go Pro

Callan JMB (CJMB) Financials

Callan JMB logo
$2.55 +0.20 (+8.51%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$2.69 +0.14 (+5.53%)
As of 07/24/2026 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Callan JMB

Annual Income Statements for Callan JMB

This table shows Callan JMB's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
2.18 -2.29 -7.97
Consolidated Net Income / (Loss)
2.18 -2.29 -7.97
Net Income / (Loss) Continuing Operations
2.18 -2.29 -7.97
Total Pre-Tax Income
2.20 -2.27 -7.97
Total Operating Income
2.20 -2.27 -7.03
Total Gross Profit
5.65 2.56 2.10
Total Revenue
13 6.56 5.72
Operating Revenue
13 6.56 5.72
Total Cost of Revenue
7.55 4.00 3.62
Operating Cost of Revenue
7.55 4.00 3.62
Total Operating Expenses
3.45 4.84 9.14
Selling, General & Admin Expense
3.45 4.84 8.60
Impairment Charge
- 0.00 0.54
Total Other Income / (Expense), net
0.00 0.01 -0.93
Interest Expense
0.01 0.01 0.00
Interest & Investment Income
0.01 0.01 0.01
Other Income / (Expense), net
- 0.00 -0.94
Income Tax Expense
0.02 0.03 -0.00
Basic Earnings per Share
$0.00 ($0.87) ($1.82)
Weighted Average Basic Shares Outstanding
0.00 2.63M 4.38M
Diluted Earnings per Share
$0.00 ($0.87) ($1.82)
Weighted Average Diluted Shares Outstanding
0.00 2.63M 4.38M
Weighted Average Basic & Diluted Shares Outstanding
- 4.44M 5.63M

Quarterly Income Statements for Callan JMB

This table shows Callan JMB's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-0.08 -0.11 -0.80 -1.30 -1.24 -1.40 -2.73 -2.60 -3.22
Consolidated Net Income / (Loss)
-0.08 -0.11 -0.80 -1.30 -1.24 -1.40 -2.73 -2.60 -3.22
Net Income / (Loss) Continuing Operations
-0.08 -0.11 -0.80 -1.30 -1.24 -1.40 -2.73 -2.60 -3.22
Total Pre-Tax Income
-0.09 -0.13 -0.78 -1.27 -1.24 -1.40 -2.73 -2.60 -3.21
Total Operating Income
-0.09 -0.13 -0.78 -1.27 -1.24 -1.40 -1.88 -2.51 -1.70
Total Gross Profit
0.72 0.96 0.46 0.42 0.62 0.64 0.49 0.35 0.43
Total Revenue
1.79 1.99 1.44 1.35 1.45 1.67 1.45 1.16 1.11
Operating Revenue
1.79 1.99 1.44 1.35 1.45 1.67 1.45 1.16 1.11
Total Cost of Revenue
1.07 1.02 0.97 0.93 0.83 1.02 0.95 0.81 0.68
Operating Cost of Revenue
1.07 1.02 0.97 0.93 0.83 1.02 0.95 0.81 0.68
Total Operating Expenses
0.81 1.10 1.25 1.69 1.85 2.05 2.37 2.87 2.13
Selling, General & Admin Expense
0.81 1.10 1.25 1.69 1.85 2.05 2.37 2.32 2.13
Total Other Income / (Expense), net
0.00 0.00 0.00 0.00 0.00 0.00 -0.85 -0.09 -1.51
Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest & Investment Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income / (Expense), net
- - 0.00 - 0.00 - -0.85 - -1.52
Income Tax Expense
-0.01 -0.02 0.03 0.03 0.00 -0.00 0.00 -0.00 0.00
Basic Earnings per Share
($0.03) ($0.04) ($0.27) ($0.53) ($0.59) ($0.31) ($0.61) ($0.58) ($0.32)
Weighted Average Basic Shares Outstanding
2.50M 3M 3M 2.63M 5.45M 4.46M 4.49M 4.38M 3.86M
Diluted Earnings per Share
($0.03) ($0.04) ($0.27) ($0.53) ($0.59) ($0.31) ($0.61) ($0.58) ($0.32)
Weighted Average Diluted Shares Outstanding
2.50M 3M 3M 2.63M 5.45M 4.46M 4.49M 4.38M 3.86M
Weighted Average Basic & Diluted Shares Outstanding
- - - 4.44M 4.44M 4.48M 4.62M 5.63M 5.65M

Annual Cash Flow Statements for Callan JMB

This table details how cash moves in and out of Callan JMB's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-1.04 -3.06 0.03
Net Cash From Operating Activities
7.00 0.54 -4.55
Net Cash From Continuing Operating Activities
7.00 0.54 -4.55
Net Income / (Loss) Continuing Operations
2.18 -2.29 -7.97
Consolidated Net Income / (Loss)
2.18 -2.29 -7.97
Depreciation Expense
0.10 0.14 0.15
Non-Cash Adjustments To Reconcile Net Income
0.28 -0.12 3.22
Changes in Operating Assets and Liabilities, net
4.44 2.81 0.04
Net Cash From Investing Activities
-0.49 -0.05 -0.62
Net Cash From Continuing Investing Activities
-0.49 -0.05 -0.62
Purchase of Property, Plant & Equipment
-0.49 -0.05 -0.62
Net Cash From Financing Activities
-7.54 -3.55 5.20
Net Cash From Continuing Financing Activities
-7.54 -3.55 5.20
Repayment of Debt
-0.14 -0.12 0.02
Payment of Dividends
-7.40 -3.33 0.00
Issuance of Debt
-0.01 0.00 0.00
Issuance of Common Equity
- 0.00 0.50
Other Financing Activities, net
- -0.11 4.68
Cash Interest Paid
0.01 0.01 0.00

Quarterly Cash Flow Statements for Callan JMB

This table details how cash moves in and out of Callan JMB's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-3.50 0.19 0.96 -0.71 3.12 -1.00 -1.43 -0.66 -0.72
Net Cash From Operating Activities
0.01 0.27 0.99 -0.72 -1.56 -0.56 -1.76 -0.66 -1.68
Net Cash From Continuing Operating Activities
0.01 0.27 0.99 -0.72 -1.56 -0.56 -1.76 -0.66 -1.68
Net Income / (Loss) Continuing Operations
-0.08 -0.11 -0.80 -1.30 -1.24 -1.40 -2.73 -2.59 -3.22
Consolidated Net Income / (Loss)
-0.08 -0.11 -0.80 -1.30 -1.24 -1.40 -2.73 -2.59 -3.22
Depreciation Expense
0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.04
Non-Cash Adjustments To Reconcile Net Income
0.00 -0.00 -0.15 0.04 0.32 0.42 1.29 1.19 2.10
Changes in Operating Assets and Liabilities, net
0.05 0.34 1.91 0.50 -0.68 0.38 -0.36 0.71 -0.60
Net Cash From Investing Activities
-0.04 -0.00 -0.00 - -0.02 -0.43 -0.17 - -0.04
Net Cash From Continuing Investing Activities
-0.04 -0.00 -0.00 - -0.02 -0.43 -0.17 - -0.04
Purchase of Property, Plant & Equipment
-0.04 -0.00 -0.00 - -0.02 -0.43 -0.17 - -0.04
Net Cash From Financing Activities
-3.46 -0.08 -0.03 0.01 4.70 - 0.50 0.00 1.00
Net Cash From Continuing Financing Activities
-3.46 -0.08 -0.03 0.01 4.70 - 0.50 0.00 1.00
Repayment of Debt
-0.04 -0.05 -0.01 -0.02 0.02 0.02 - - 0.00
Issuance of Common Equity
- - - - 0.00 - - - 1.00
Other Financing Activities, net
-0.04 -0.02 -0.02 -0.03 4.68 -0.02 - 0.00 0.00
Cash Interest Paid
0.00 0.00 0.00 - 0.00 - 0.00 0.00 0.00

Annual Balance Sheets for Callan JMB

This table presents Callan JMB's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets
9.71 5.08 5.78
Total Current Assets
8.45 3.32 3.06
Cash & Equivalents
5.16 2.10 2.13
Accounts Receivable
2.92 0.64 0.34
Inventories, net
0.11 0.16 0.24
Other Current Assets
0.26 0.41 0.34
Plant, Property, & Equipment, net
0.97 0.88 0.80
Total Noncurrent Assets
0.28 0.89 1.92
Other Noncurrent Operating Assets
0.28 0.89 1.92
Total Liabilities & Shareholders' Equity
9.71 5.08 5.78
Total Liabilities
0.91 1.91 3.45
Total Current Liabilities
0.77 1.27 1.41
Accounts Payable
0.42 0.37 0.56
Accrued Expenses
- 0.51 0.50
Current Deferred & Payable Income Tax Liabilities
0.07 0.02 0.02
Other Current Liabilities
0.15 0.28 0.32
Total Noncurrent Liabilities
0.14 0.63 2.03
Other Noncurrent Operating Liabilities
0.13 0.63 2.03
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
8.80 3.17 2.33
Total Preferred & Common Equity
8.80 3.17 2.33
Preferred Stock
0.00 0.00 0.00
Total Common Equity
8.80 3.17 2.33
Common Stock
8.80 5.47 13
Retained Earnings
0.00 -2.29 -10

Quarterly Balance Sheets for Callan JMB

This table presents Callan JMB's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
8.46 8.97 7.74 5.71
Total Current Assets
6.80 5.59 4.29 3.03
Cash & Equivalents
5.22 4.22 2.79 1.42
Accounts Receivable
0.83 0.61 0.95 0.82
Inventories, net
0.22 0.20 0.22 0.22
Other Current Assets
0.18 0.48 0.30 0.58
Plant, Property, & Equipment, net
0.85 1.25 1.37 0.80
Total Noncurrent Assets
0.80 2.13 2.07 1.88
Other Noncurrent Operating Assets
0.80 2.13 2.07 1.88
Total Liabilities & Shareholders' Equity
8.46 8.97 7.74 5.71
Total Liabilities
1.65 3.14 3.56 4.11
Total Current Liabilities
1.05 1.31 1.19 1.52
Accounts Payable
0.39 0.43 0.32 0.58
Accrued Expenses
0.39 0.52 0.52 0.57
Current Deferred & Payable Income Tax Liabilities
0.03 0.03 0.03 0.02
Other Current Liabilities
0.24 0.33 0.33 0.34
Total Noncurrent Liabilities
0.60 1.83 2.37 2.60
Other Noncurrent Operating Liabilities
0.59 1.83 2.37 2.60
Commitments & Contingencies
0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
6.81 5.83 4.18 1.60
Total Preferred & Common Equity
6.81 5.83 4.18 1.60
Preferred Stock
0.00 0.00 0.00 0.00
Total Common Equity
6.81 5.83 4.18 1.60
Common Stock
10 11 12 15
Retained Earnings
-3.53 -4.94 -7.67 -13

Annual Metrics And Ratios for Callan JMB

This table displays calculated financial ratios and metrics derived from Callan JMB's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 4,623,027.00
DEI Adjusted Shares Outstanding
0.00 0.00 4,623,027.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -1.72
Growth Metrics
- - -
Revenue Growth
0.00% -50.29% -12.80%
EBITDA Growth
0.00% -192.46% -267.10%
EBIT Growth
0.00% -203.30% -250.59%
NOPAT Growth
0.00% -173.08% -209.24%
Net Income Growth
0.00% -205.16% -247.32%
EPS Growth
0.00% 0.00% -109.20%
Operating Cash Flow Growth
0.00% -92.28% -941.44%
Free Cash Flow Firm Growth
0.00% 0.00% -471.97%
Invested Capital Growth
0.00% -71.36% -81.66%
Revenue Q/Q Growth
0.00% 0.00% -3.23%
EBITDA Q/Q Growth
0.00% 0.00% -38.77%
EBIT Q/Q Growth
0.00% 0.00% -37.67%
NOPAT Q/Q Growth
0.00% 0.00% -21.43%
Net Income Q/Q Growth
0.00% 0.00% -19.53%
EPS Q/Q Growth
0.00% 0.00% -2.82%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 1.39%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% -85.77%
Profitability Metrics
- - -
Gross Margin
42.79% 39.05% 36.77%
EBITDA Margin
17.46% -32.47% -136.70%
Operating Margin
16.68% -34.66% -122.91%
EBIT Margin
16.68% -34.66% -139.35%
Profit (Net Income) Margin
16.52% -34.95% -139.19%
Tax Burden Percent
98.96% 101.12% 99.96%
Interest Burden Percent
100.09% 99.71% 99.92%
Effective Tax Rate
1.04% 0.00% 0.00%
Return on Invested Capital (ROIC)
58.02% -65.92% -773.82%
ROIC Less NNEP Spread (ROIC-NNEP)
57.98% -46.27% -629.94%
Return on Net Nonoperating Assets (RNNOA)
-33.22% 27.60% 484.21%
Return on Equity (ROE)
24.80% -38.33% -289.61%
Cash Return on Invested Capital (CROIC)
0.00% 45.03% -635.83%
Operating Return on Assets (OROA)
22.69% -30.77% -146.90%
Return on Assets (ROA)
22.47% -31.02% -146.73%
Return on Common Equity (ROCE)
24.80% -38.33% -289.61%
Return on Equity Simple (ROE_SIMPLE)
24.80% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
2.18 -1.59 -4.92
NOPAT Margin
16.51% -24.26% -86.04%
Net Nonoperating Expense Percent (NNEP)
0.04% -19.65% -143.88%
Return On Investment Capital (ROIC_SIMPLE)
24.45% -50.18% -211.52%
Cost of Revenue to Revenue
57.21% 60.95% 63.23%
SG&A Expenses to Revenue
26.11% 73.71% 150.21%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
26.11% 73.71% 159.69%
Earnings before Interest and Taxes (EBIT)
2.20 -2.27 -7.98
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2.30 -2.13 -7.82
Valuation Ratios
- - -
Price to Book Value (P/BV)
0.58 1.61 2.09
Price to Tangible Book Value (P/TBV)
0.58 1.61 2.09
Price to Revenue (P/Rev)
0.39 0.78 0.85
Price to Earnings (P/E)
2.35 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
42.60% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.02 2.81 13.84
Enterprise Value to Revenue (EV/Rev)
0.01 0.46 0.48
Enterprise Value to EBITDA (EV/EBITDA)
0.03 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.04 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.04 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.01 5.59 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 2.78 0.00
Leverage & Solvency
- - -
Debt to Equity
0.01 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00
Financial Leverage
-0.57 -0.60 -0.77
Leverage Ratio
1.10 1.24 1.97
Compound Leverage Factor
1.10 1.23 1.97
Debt to Total Capital
1.30% 0.00% 0.00%
Short-Term Debt to Total Capital
1.30% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
98.70% 100.00% 100.00%
Debt to EBITDA
0.05 0.00 0.00
Net Debt to EBITDA
-2.19 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00
Debt to NOPAT
0.05 0.00 0.00
Net Debt to NOPAT
-2.31 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00
Altman Z-Score
6.43 1.27 -4.87
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
10.98 2.60 2.16
Quick Ratio
10.49 2.15 1.75
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
0.00 1.09 -4.05
Operating Cash Flow to CapEx
1,427.62% 1,170.43% -737.03%
Free Cash Flow to Firm to Interest Expense
0.00 202.48 -1,512.55
Operating Cash Flow to Interest Expense
860.37 100.59 -1,699.71
Operating Cash Flow Less CapEx to Interest Expense
800.10 91.99 -1,930.33
Efficiency Ratios
- - -
Asset Turnover
1.36 0.89 1.05
Accounts Receivable Turnover
4.52 3.68 11.62
Inventory Turnover
65.83 29.29 18.02
Fixed Asset Turnover
13.55 7.09 6.83
Accounts Payable Turnover
18.15 10.16 7.73
Days Sales Outstanding (DSO)
80.76 99.06 31.40
Days Inventory Outstanding (DIO)
5.54 12.46 20.26
Days Payable Outstanding (DPO)
20.11 35.94 47.19
Cash Conversion Cycle (CCC)
66.20 75.58 4.47
Capital & Investment Metrics
- - -
Invested Capital
3.76 1.08 0.20
Invested Capital Turnover
3.52 2.72 8.99
Increase / (Decrease) in Invested Capital
0.00 -2.68 -0.88
Enterprise Value (EV)
0.08 3.02 2.73
Market Capitalization
5.12 5.12 4.86
Book Value per Share
$6.87 $1.21 $0.50
Tangible Book Value per Share
$6.87 $1.21 $0.50
Total Capital
8.91 3.17 2.33
Total Debt
0.12 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00
Net Debt
-5.04 -2.10 -2.13
Capital Expenditures (CapEx)
0.49 0.05 0.62
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2.64 -0.05 -0.49
Debt-free Net Working Capital (DFNWC)
7.80 2.04 1.65
Net Working Capital (NWC)
7.68 2.04 1.65
Net Nonoperating Expense (NNE)
-0.00 0.70 3.04
Net Nonoperating Obligations (NNO)
-5.04 -2.10 -2.13
Total Depreciation and Amortization (D&A)
0.10 0.14 0.15
Debt-free, Cash-free Net Working Capital to Revenue
20.02% -0.81% -8.48%
Debt-free Net Working Capital to Revenue
59.07% 31.16% 28.75%
Net Working Capital to Revenue
58.19% 31.16% 28.75%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 ($0.87) ($1.82)
Adjusted Weighted Average Basic Shares Outstanding
0.00 2.63M 4.38M
Adjusted Diluted Earnings per Share
$0.00 ($0.87) ($1.82)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 2.63M 4.38M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 4.44M 5.63M
Normalized Net Operating Profit after Tax (NOPAT)
2.18 -1.59 -4.54
Normalized NOPAT Margin
16.51% -24.26% -79.41%
Pre Tax Income Margin
16.69% -34.56% -139.25%
Debt Service Ratios
- - -
EBIT to Interest Expense
270.82 -423.46 -2,981.44
NOPAT to Interest Expense
268.00 -296.42 -1,840.82
EBIT Less CapEx to Interest Expense
210.56 -432.05 -3,212.05
NOPAT Less CapEx to Interest Expense
207.73 -305.01 -2,071.44
Payout Ratios
- - -
Dividend Payout Ratio
339.13% -145.11% 0.00%
Augmented Payout Ratio
339.13% -145.11% 0.00%

Quarterly Metrics And Ratios for Callan JMB

This table displays calculated financial ratios and metrics derived from Callan JMB's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
0.00 0.00 0.00 0.00 4,443,569.00 4,443,569.00 4,481,069.00 4,623,027.00 5,627,368.00
DEI Adjusted Shares Outstanding
0.00 0.00 0.00 0.00 4,443,569.00 4,443,569.00 4,481,069.00 4,623,027.00 5,627,368.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 0.00 0.00 -0.28 -0.31 -0.61 -0.56 -0.57
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% -19.05% -16.09% 0.80% -14.14% -23.68%
EBITDA Growth
0.00% 0.00% 0.00% 0.00% -2,213.99% -1,312.53% -260.77% -100.60% -164.82%
EBIT Growth
0.00% 0.00% 0.00% 0.00% -1,315.95% -951.29% -249.85% -97.52% -159.75%
NOPAT Growth
0.00% 0.00% 0.00% 0.00% -1,315.95% -951.29% -140.61% -97.52% -37.37%
Net Income Growth
0.00% 0.00% 0.00% 0.00% -1,429.08% -1,142.51% -239.30% -100.53% -159.16%
EPS Growth
0.00% 0.00% 0.00% 0.00% -1,866.67% -675.00% -125.93% -9.43% 45.76%
Operating Cash Flow Growth
0.00% 0.00% 0.00% 0.00% -22,935.18% -309.64% -278.42% 8.88% -7.57%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 108.67%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -81.66% -88.41%
Revenue Q/Q Growth
0.00% 10.90% -27.72% -5.83% 7.22% 14.97% -13.17% -19.79% -4.69%
EBITDA Q/Q Growth
0.00% -86.14% -671.80% -66.00% 2.97% -13.63% -97.12% 7.69% -28.09%
EBIT Q/Q Growth
0.00% -52.55% -485.34% -62.99% 2.72% -13.27% -94.79% 7.97% -27.93%
NOPAT Q/Q Growth
0.00% -52.55% -485.34% -62.99% 2.72% -13.27% -33.97% -33.80% 32.34%
Net Income Q/Q Growth
0.00% -38.63% -615.70% -60.88% 4.21% -12.65% -95.44% 4.92% -23.80%
EPS Q/Q Growth
0.00% -33.33% -575.00% -96.30% -11.32% 3.13% -96.77% 4.92% 44.83%
Operating Cash Flow Q/Q Growth
0.00% 3,828.72% 267.72% -173.20% -115.95% 63.93% -212.95% 62.62% -154.92%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% -5.23% -4.58% 67.35% 124.13%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 47.63% 0.85% -13.44% -85.77% -6.75%
Profitability Metrics
- - - - - - - - -
Gross Margin
40.08% 48.46% 32.36% 31.00% 42.50% 38.64% 34.09% 30.28% 38.62%
EBITDA Margin
-2.90% -4.86% -51.93% -91.53% -82.83% -81.86% -185.84% -213.87% -287.42%
Operating Margin
-4.88% -6.72% -54.41% -94.17% -85.44% -84.18% -129.87% -216.65% -153.79%
EBIT Margin
-4.88% -6.72% -54.41% -94.17% -85.44% -84.18% -188.83% -216.65% -290.80%
Profit (Net Income) Margin
-4.53% -5.66% -56.08% -95.81% -85.59% -83.87% -188.77% -223.76% -290.65%
Tax Burden Percent
93.11% 84.90% 103.34% 102.00% 100.35% 99.78% 100.00% 99.84% 100.01%
Interest Burden Percent
99.63% 99.29% 99.74% 99.74% 99.83% 99.85% 99.97% 103.45% 99.94%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% -402.32% -468.81% -434.47% -775.93% -1,363.95% -653.85%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% -383.06% -454.49% -414.79% -674.42% -1,324.37% -592.84%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 253.25% 348.49% 300.78% 450.58% 1,017.99% 467.91%
Return on Equity (ROE)
0.00% 0.00% 0.00% -149.07% -120.31% -133.69% -325.35% -345.96% -185.94%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 101.15% 0.00% 0.00% 0.00% -635.83% -434.01%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% -83.59% -62.87% -55.42% -144.36% -228.38% -220.88%
Return on Assets (ROA)
0.00% 0.00% 0.00% -85.04% -62.99% -55.22% -144.32% -235.88% -220.77%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% -149.07% -120.31% -133.69% -325.35% -345.96% -185.94%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-0.06 -0.09 -0.55 -0.89 -0.87 -0.98 -1.32 -1.76 -1.19
NOPAT Margin
-3.42% -4.70% -38.09% -65.92% -59.81% -58.92% -90.91% -151.65% -107.66%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% -19.26% -14.32% -19.68% -101.51% -39.58% -61.01%
Return On Investment Capital (ROIC_SIMPLE)
- - - -28.08% -12.73% -16.86% -31.50% -75.60% -74.45%
Cost of Revenue to Revenue
59.92% 51.54% 67.64% 69.00% 57.50% 61.36% 65.91% 69.72% 61.38%
SG&A Expenses to Revenue
44.96% 55.17% 86.77% 125.17% 127.94% 122.82% 163.97% 200.22% 192.42%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
44.96% 55.17% 86.77% 125.17% 127.94% 122.82% 163.97% 246.93% 192.42%
Earnings before Interest and Taxes (EBIT)
-0.09 -0.13 -0.78 -1.27 -1.24 -1.40 -2.73 -2.51 -3.22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-0.05 -0.10 -0.75 -1.24 -1.20 -1.36 -2.69 -2.48 -3.18
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 1.61 3.60 3.92 5.25 2.09 3.02
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 1.61 3.60 3.92 5.25 2.09 3.02
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.78 3.94 3.87 3.70 0.85 0.90
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 2.81 12.14 11.63 13.80 13.84 18.55
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.46 3.10 3.15 3.23 0.48 0.63
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 5.59 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 0.00 0.00 -0.66 -0.77 -0.73 -0.67 -0.77 -0.79
Leverage Ratio
0.00 0.00 0.00 1.24 1.24 1.54 1.85 1.97 1.69
Compound Leverage Factor
0.00 0.00 0.00 1.23 1.24 1.54 1.85 2.04 1.68
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 0.00% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 0.00 0.00 1.92 9.40 4.31 2.39 -1.74 -3.20
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - -
Current Ratio
0.00 0.00 0.00 2.60 6.49 4.26 3.60 2.16 2.00
Quick Ratio
0.00 0.00 0.00 2.15 5.77 3.69 3.14 1.75 1.48
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 0.00 0.00 -2.45 -2.58 -2.70 -0.88 0.21
Operating Cash Flow to CapEx
15.31% 22,059.52% 337,202.05% 0.00% -10,411.32% -130.23% -1,040.66% 0.00% -4,757.25%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 -38,960.56 0.00 -5,711.03 -412.31 0.00
Operating Cash Flow to Interest Expense
2.20 148.77 2,157.21 -723,173.00 -24,788.86 0.00 -3,726.78 -308.08 0.00
Operating Cash Flow Less CapEx to Interest Expense
-12.17 148.10 2,156.57 -723,173.00 -25,026.95 0.00 -4,084.90 -308.08 0.00
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.89 0.74 0.66 0.76 1.05 0.76
Accounts Receivable Turnover
0.00 0.00 0.00 3.68 7.45 9.61 6.25 11.62 6.49
Inventory Turnover
0.00 0.00 0.00 29.29 17.41 19.04 16.76 18.02 15.96
Fixed Asset Turnover
0.00 0.00 0.00 7.09 7.29 4.73 4.30 6.83 6.52
Accounts Payable Turnover
0.00 0.00 0.00 10.16 9.64 8.73 11.74 7.73 7.12
Days Sales Outstanding (DSO)
0.00 0.00 0.00 99.06 48.98 37.98 58.37 31.40 56.26
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 12.46 20.97 19.18 21.77 20.26 22.87
Days Payable Outstanding (DPO)
0.00 0.00 0.00 35.94 37.85 41.83 31.09 47.19 51.27
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 75.58 32.10 15.32 49.05 4.47 27.86
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
0.00 0.00 0.00 1.08 1.59 1.60 1.39 0.20 0.18
Invested Capital Turnover
0.00 0.00 0.00 6.10 7.84 7.37 8.54 8.99 6.07
Increase / (Decrease) in Invested Capital
0.00 0.00 0.00 0.00 1.59 1.60 1.39 -0.88 -1.40
Enterprise Value (EV)
0.00 0.00 0.00 3.02 19 19 19 2.73 3.41
Market Capitalization
5.12 5.12 5.12 5.12 24 23 22 4.86 4.83
Book Value per Share
$0.00 $0.00 $0.00 $1.21 $1.53 $1.31 $0.93 $0.50 $0.35
Tangible Book Value per Share
$0.00 $0.00 $0.00 $1.21 $1.53 $1.31 $0.93 $0.50 $0.35
Total Capital
0.00 0.00 0.00 3.17 6.81 5.83 4.18 2.33 1.60
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
0.00 0.00 0.00 -2.10 -5.22 -4.22 -2.79 -2.13 -1.42
Capital Expenditures (CapEx)
0.04 0.00 0.00 0.00 0.02 0.43 0.17 0.00 0.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 0.00 0.00 -0.05 0.53 0.05 0.31 -0.49 0.10
Debt-free Net Working Capital (DFNWC)
0.00 0.00 0.00 2.04 5.75 4.28 3.10 1.65 1.52
Net Working Capital (NWC)
0.00 0.00 0.00 2.04 5.75 4.28 3.10 1.65 1.52
Net Nonoperating Expense (NNE)
0.02 0.02 0.26 0.40 0.37 0.42 1.42 0.84 2.02
Net Nonoperating Obligations (NNO)
0.00 0.00 0.00 -2.10 -5.22 -4.22 -2.79 -2.13 -1.42
Total Depreciation and Amortization (D&A)
0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.04
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% -0.81% 8.57% 0.93% 5.27% -8.48% 1.93%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 31.16% 92.46% 72.49% 52.44% 28.75% 28.24%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 31.16% 92.46% 72.49% 52.44% 28.75% 28.24%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 ($0.53) ($0.32) ($0.31) ($0.61) ($0.58) ($0.32)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 2.63M 3.86M 4.46M 4.49M 4.38M 3.86M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 ($0.53) ($0.32) ($0.31) ($0.61) ($0.58) ($0.32)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 2.63M 3.86M 4.46M 4.49M 4.38M 3.86M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 4.44M 4.44M 4.48M 4.62M 5.63M 5.65M
Normalized Net Operating Profit after Tax (NOPAT)
-0.06 -0.09 -0.55 -0.89 -0.87 -0.98 -1.32 -1.76 -1.19
Normalized NOPAT Margin
-3.42% -4.70% -38.09% -65.92% -59.81% -58.92% -90.91% -151.65% -107.66%
Pre Tax Income Margin
-4.87% -6.67% -54.27% -93.93% -85.29% -84.06% -188.77% -224.12% -290.63%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
-28.15 -73.88 -1,705.20 -1,272,949.00 -19,656.76 0.00 -5,776.41 -1,175.49 0.00
NOPAT to Interest Expense
-19.70 -51.71 -1,193.64 -891,064.30 -13,759.73 0.00 -2,780.99 -822.84 0.00
EBIT Less CapEx to Interest Expense
-42.52 -74.55 -1,705.84 -1,272,949.00 -19,894.86 0.00 -6,134.52 -1,175.49 0.00
NOPAT Less CapEx to Interest Expense
-34.08 -52.39 -1,194.28 -891,064.30 -13,997.83 0.00 -3,139.11 -822.84 0.00
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% -145.11% 0.00% 1.14% 0.81% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% -145.11% 0.00% 1.14% 0.81% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Callan JMB Inc. (NASDAQ: CJMB) continues to post top-line growth, but profitability and operating cash flow remain under significant pressure. Over the last four years, revenue has generally trended higher than early 2024 levels, but operating expenses have risen faster than gross profit, keeping the company deeply unprofitable. The balance sheet also shows a meaningful increase in equity, but much of that appears tied to capital raises rather than sustained earnings power.

  • Revenue improved year over year in recent quarters, with Q1 2026 revenue of $1.11 million compared with $1.45 million in Q1 2025 and $1.79 million in Q1 2024.
  • Gross profit remained positive in every quarter shown, including $427 thousand in Q1 2026, indicating the core business still generates margin above direct costs.
  • Cash and equivalents were still $1.42 million at the end of Q1 2026, giving the company some short-term liquidity.
  • Common equity increased sharply over the period, reaching $1.60 million in Q1 2026 from $6.81 million in Q1 2025 and $4.18 million in Q3 2025, reflecting ongoing capital support.
  • Q1 2026 operating cash burn improved versus some prior periods, but the company still used $1.68 million in operating cash during the quarter.
  • The company has continued to invest modestly in property and equipment, with Q1 2026 capex of just $35 thousand.
  • Basic and diluted EPS were both -$0.32 in Q1 2026, worse than Q1 2025’s -$0.59 on a per-share basis but still deeply negative.
  • Operating income remains heavily negative, with Q1 2026 operating loss of $1.70 million after $2.13 million of SG&A expense against only $427 thousand of gross profit.
  • The company posted a net loss of $3.22 million in Q1 2026, wider than the $2.60 million loss in Q4 2025 and $1.24 million loss in Q1 2025.
  • Other income/expense was a major drag in Q1 2026, with -$1.52 million in net other expense, suggesting non-operating items are materially hurting results.
  • Despite the larger equity base, the company’s retained earnings deficit widened to -$13.48 million in Q1 2026, underscoring cumulative losses.
  • Operating cash flow has been negative in the latest quarter and in several recent periods, including -$659 thousand in Q4 2025 and -$1.76 million in Q3 2025.

Bottom line: CJMB shows signs of revenue stabilization and still has liquidity, but the business is not yet producing consistent profits or positive operating cash flow. The biggest concern for investors is that expenses, especially SG&A and other non-operating costs, are far outpacing gross profit. Until the company demonstrates sustained operating leverage, the stock likely remains a high-risk turnaround story.

07/26/26 12:10 PM ETAI Generated. May Contain Errors.

Callan JMB Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Callan JMB's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Callan JMB's net income appears to be on an upward trend, with a most recent value of -$7.97 million in 2025, falling from $2.18 million in 2023. The previous period was -$2.29 million in 2024. Find out what analysts predict for Callan JMB in the coming months.

Callan JMB's total operating income in 2025 was -$7.03 million, based on the following breakdown:
  • Total Gross Profit: $2.10 million
  • Total Operating Expenses: $9.14 million

Over the last 2 years, Callan JMB's total revenue changed from $13.20 million in 2023 to $5.72 million in 2025, a change of -56.7%.

Callan JMB's total liabilities were at $3.45 million at the end of 2025, a 80.6% increase from 2024, and a 278.8% increase since 2023.

In the past 2 years, Callan JMB's cash and equivalents has ranged from $2.10 million in 2024 to $5.16 million in 2023, and is currently $2.13 million as of their latest financial filing in 2025.

Over the last 2 years, Callan JMB's book value per share changed from 6.87 in 2023 to 0.50 in 2025, a change of -92.7%.



Financial statements for NASDAQ:CJMB last updated on 7/23/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners